As a Physician Founder, you're embarking on a one-of-a-kind week of advanced longevity training, positioning yourself at the cutting edge of integrative medicine and metabolic rejuvenation

It's not seen with: Semaglutide (Wegovy/Ozempic): 10% body weight quickly Hypoglycemia (Low Blood Sugar): Rare in non-diabetics ( perceived benefit) Timeline of Side Effects: What to Expect Week by Week Week 14: Initial Dose (2mg) What's happening: Body adjusting to GLP-1 activation Common side effects: Mild nausea (2030%): Usually 12 hours after injection Reduced appetite (desired!) Occasional loose stools Mild fatigue Duration: Usually 25 days after each injection, then improves Management: Take with food, stay hydrated, avoid high-fat meals Week 58: First Dose Increase (4mg) What's happening: GLP-1 effects intensifying Common side effects: Nausea increases (3040%) Diarrhea or constipation (1525%) Fullness sensation (desired effect) Energy fluctuations Duration: Peak in first 23 days after dose increase, then stabilizes Management: Smaller, more frequent meals

Tirzepatide is a dual GIP/GLP-1 agonist with a different molecular structure, which means its degradation characteristics are not identical
For weight management, NICE has approved semaglutide (Wegovy) for adults with specific BMI criteria (35 kg/m or 30 kg/m with weight-related comorbidities) within specialist weight management services
Stacking DSIP with Other Compounds Some users combine DSIP with other compounds to enhance sleep quality or address multiple aspects of recovery